270 related articles for article (PubMed ID: 11577082)
21. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
[TBL] [Abstract][Full Text] [Related]
22. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
[TBL] [Abstract][Full Text] [Related]
23. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
Lau PP; Zhu HJ; Nakamuta M; Chan L
J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
[TBL] [Abstract][Full Text] [Related]
24. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
[TBL] [Abstract][Full Text] [Related]
25. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
26. Hypermutation induced by APOBEC-1 overexpression can be eliminated.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Csako G; Patterson AP
RNA; 2010 May; 16(5):1040-52. PubMed ID: 20348446
[TBL] [Abstract][Full Text] [Related]
27. A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling.
Blanc V; Kennedy S; Davidson NO
J Biol Chem; 2003 Oct; 278(42):41198-204. PubMed ID: 12896982
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
Sowden MP; Eagleton MJ; Smith HC
Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
[TBL] [Abstract][Full Text] [Related]
29. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
Chester A; Scott J; Anant S; Navaratnam N
Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes.
Greeve J; Lellek H; Rautenberg P; Greten H
Biol Chem; 1998; 379(8-9):1063-73. PubMed ID: 9792439
[TBL] [Abstract][Full Text] [Related]
31. Analysis of protein complexes assembled on apolipoprotein B mRNA for mooring sequence-dependent RNA editing.
Smith HC
Methods; 1998 May; 15(1):27-39. PubMed ID: 9614650
[TBL] [Abstract][Full Text] [Related]
32. Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome.
Lau PP; Chang BH; Chan L
Biochem Biophys Res Commun; 2001 Apr; 282(4):977-83. PubMed ID: 11352648
[TBL] [Abstract][Full Text] [Related]
33. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.
Chester A; Somasekaram A; Tzimina M; Jarmuz A; Gisbourne J; O'Keefe R; Scott J; Navaratnam N
EMBO J; 2003 Aug; 22(15):3971-82. PubMed ID: 12881431
[TBL] [Abstract][Full Text] [Related]
34. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs.
Sowden M; Hamm JK; Spinelli S; Smith HC
RNA; 1996 Mar; 2(3):274-88. PubMed ID: 8608451
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing.
Sowden M; Hamm JK; Smith HC
J Biol Chem; 1996 Feb; 271(6):3011-7. PubMed ID: 8621694
[TBL] [Abstract][Full Text] [Related]
36. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
37. Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene.
Henderson JO; Blanc V; Davidson NO
Biochim Biophys Acta; 2001 Nov; 1522(1):22-30. PubMed ID: 11718896
[TBL] [Abstract][Full Text] [Related]
38. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48.
Giannoni F; Bonen DK; Funahashi T; Hadjiagapiou C; Burant CF; Davidson NO
J Biol Chem; 1994 Feb; 269(8):5932-6. PubMed ID: 8119937
[TBL] [Abstract][Full Text] [Related]
39. The binding of apobec-1 to mammalian apo B RNA is stabilized by the presence of complementation factors which are required for post-transcriptional editing.
Anant S; MacGinnitie AJ; Davidson NO
Nucleic Acids Symp Ser; 1995; (33):99-102. PubMed ID: 8643413
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction.
Yang Y; Ballatori N; Smith HC
Mol Pharmacol; 2002 Feb; 61(2):269-76. PubMed ID: 11809850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
